查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451212

2024-2032 年按产品和服务类型、测试类型、疾病、最终用户和地区分類的呼吸诊断市场报告

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年全球呼吸诊断市场规模达80亿美元。展望未来， IMARC Group预计到2032年市场规模将达到147亿美元，2024-2032年复合年增长率（CAGR）为6.8%。

呼吸诊断是指肺功能和相关过程的临床评估。它包括多种机械、影像和分子诊断测试，用于检测气喘、慢性阻塞性肺病 (COPD)、肺癌、支气管炎和肺纤维化。它使用的程序包括肺活量测定、血氧测定、经皮二氧化碳监测、鼻吸气压 (SNIP)、胸部 X 光检查和电脑断层扫描 (CT) 扫描。在某些情况下，还进行睡眠研究来诊断和评估睡眠呼吸中止症和夜间通气不足的存在。

呼吸系统疾病的日益普及是推动市场成长的关键因素之一。吸烟和饮酒人数不断增加，加上久坐的生活习惯和压力过大，导致慢性阻塞性肺病和肺癌等其他严重呼吸道疾病的发生率上升。此外，呼吸诊断测试的各种技术创新，包括利用物联网（IoT）和人工智慧（AI）来诊断慢性阻塞性肺病和门诊管理，正在对市场成长产生积极影响。此外，各种私人医院和医疗中心对呼吸诊断设备的需求增加，以及政府和非政府组织 (NGO) 为向所有人提供优质医疗设施而做出的努力，正在推动呼吸诊断市场的发展。其他促进市场成长的因素包括加强研发（R＆D）、不断增加的老年人口、快速城市化和不断增加的工业设施以及全球污染水平的不断上升。

本报告回答的关键问题：

  • 迄今为止，全球呼吸诊断市场表现如何，未来几年将如何表现？
  • 全球呼吸诊断产业的主要区域市场有哪些？
  • COVID-19 对全球呼吸诊断产业有何影响？
  • 基于产品和服务类型的市场区隔是什么？
  • 根据测试类型，市场的细分是什么？
  • 基于疾病的市场崩盘是什么？
  • 基于最终用户的市场区隔是什么？
  • 全球呼吸诊断产业价值链的各个阶段是什么？
  • 全球呼吸诊断产业的关键驱动因素和挑战是什么？
  • 全球呼吸诊断产业的结构如何？谁是关键参与者？
  • 全球呼吸诊断产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球呼吸诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：依产品及服务类型
  • 市场区隔：按测试类型
  • 市场区隔：依疾病分类
  • 市场区隔：按最终用户
  • 市场区隔：按地区
  • 市场预测

第 6 章：市场区隔：依产品与服务类型

  • 仪器和服务
    • 市场走向
    • 市场预测
  • 测定和试剂
    • 市场走向
    • 市场预测
  • 服务和软体
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按测试类型

  • 机械测试
    • 市场走向
    • 市场预测
  • 阻塞性睡眠呼吸中止症 (OSA) 诊断测试
    • 市场走向
    • 市场预测
  • 影像学检查
    • 市场走向
    • 市场预测
  • 传统诊断测试
    • 市场走向
    • 市场预测
  • 分子诊断测试
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依疾病分类

  • 结核
    • 市场走向
    • 市场预测
  • 气喘
    • 市场走向
    • 市场预测
  • 慢性阻塞性肺病（COPD）
    • 市场走向
    • 市场预测
  • 肺癌
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 参考和临床实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
Product Code: SR112024A1620

The global respiratory diagnostics market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory diagnostics market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product and service type, test type, disease and end-user.

Breakup by Product and Service Type:

Instruments and Services

Assays and Reagents

Services and Software

Breakup by Test Type:

Mechanical Tests

Obstructive Sleep Apnoea (OSA) Diagnostic Tests

Imaging Tests

Traditional Diagnostic Tests

Molecular Diagnostic Tests

Others

Breakup by Disease:

Tuberculosis

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Lung Cancer

Others

Breakup by End-User:

Hospitals

Clinics

Reference and Clinical Laboratories

Others

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:

  • How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global respiratory diagnostics industry?
  • What has been the impact of COVID-19 on the global respiratory diagnostics industry?
  • What is the breakup of the market based on the product and service type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global respiratory diagnostics industry?
  • What are the key driving factors and challenges in the global respiratory diagnostics industry?
  • What is the structure of the global respiratory diagnostics industry and who are the key players?
  • What is the degree of competition in the global respiratory diagnostics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Service Type
  • 5.5 Market Breakup by Test Type
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product and Service Type

  • 6.1 Instruments and Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assays and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Mechanical Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Imaging Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Traditional Diagnostic Tests
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Molecular Diagnostic Tests
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Tuberculosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Asthma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Reference and Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Philips Healthcare
    • 14.3.2 Abbott Laboratories
    • 14.3.3 Biomerieux
    • 14.3.4 Becton Dickinson
    • 14.3.5 Thermo Fisher Scientific Inc.
    • 14.3.6 Alere Inc.
    • 14.3.7 Seegene Inc.
    • 14.3.8 3M
    • 14.3.9 Bio-Rad Laboratories Inc.
    • 14.3.10 SDI Diagnostics
    • 14.3.11 COSMED

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2023
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 11: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: North America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Latin America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million US$), 2024-2032
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players